There is an urgent need to consider solutions to overcome complex access challenges to combination therapies — payers, policymakers and industry leaders must work together and act now to ensure access.
In January 2025 the EU HTA Regulation will become reality. Let’s work together to ensure it facilitates faster patient access to new cancer treatments.
Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of in…
